1. Home
  2. WDAY vs MDAIW Comparison

WDAY vs MDAIW Comparison

Compare WDAY & MDAIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WDAY
  • MDAIW
  • Stock Information
  • Founded
  • WDAY 2005
  • MDAIW N/A
  • Country
  • WDAY United States
  • MDAIW United States
  • Employees
  • WDAY N/A
  • MDAIW 78
  • Industry
  • WDAY EDP Services
  • MDAIW Medical/Dental Instruments
  • Sector
  • WDAY Technology
  • MDAIW Health Care
  • Exchange
  • WDAY Nasdaq
  • MDAIW Nasdaq
  • Market Cap
  • WDAY N/A
  • MDAIW N/A
  • IPO Year
  • WDAY 2012
  • MDAIW N/A
  • Fundamental
  • Price
  • WDAY $232.01
  • MDAIW $0.49
  • Analyst Decision
  • WDAY Buy
  • MDAIW
  • Analyst Count
  • WDAY 26
  • MDAIW 0
  • Target Price
  • WDAY $284.72
  • MDAIW N/A
  • AVG Volume (30 Days)
  • WDAY 4.0M
  • MDAIW 35.6K
  • Earning Date
  • WDAY 08-21-2025
  • MDAIW 02-27-2025
  • Dividend Yield
  • WDAY N/A
  • MDAIW N/A
  • EPS Growth
  • WDAY N/A
  • MDAIW N/A
  • EPS
  • WDAY 2.16
  • MDAIW N/A
  • Revenue
  • WDAY $8,959,000,000.00
  • MDAIW $27,264,000.00
  • Revenue This Year
  • WDAY $14.85
  • MDAIW N/A
  • Revenue Next Year
  • WDAY $13.04
  • MDAIW N/A
  • P/E Ratio
  • WDAY $106.87
  • MDAIW N/A
  • Revenue Growth
  • WDAY 13.94
  • MDAIW 44.52
  • 52 Week Low
  • WDAY $205.33
  • MDAIW $0.08
  • 52 Week High
  • WDAY $294.00
  • MDAIW $0.90
  • Technical
  • Relative Strength Index (RSI)
  • WDAY 53.96
  • MDAIW N/A
  • Support Level
  • WDAY $227.00
  • MDAIW N/A
  • Resistance Level
  • WDAY $235.32
  • MDAIW N/A
  • Average True Range (ATR)
  • WDAY 5.67
  • MDAIW 0.00
  • MACD
  • WDAY 1.22
  • MDAIW 0.00
  • Stochastic Oscillator
  • WDAY 79.02
  • MDAIW 0.00

About MDAIW Spectral AI Inc.

Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.

Share on Social Networks: